571-585 of 831
Updates From the European Autism Interventions (EU-AIMS) Consortium
Autism SpectrumUpdates From the European Autism Interventions (EU-AIMS) Consortium
Translational Research for Autism Spectrum Disorder
Autism SpectrumTranslational Research for Autism Spectrum Disorder
The Parent's Perspectives on Autism Spectrum Disorder
Autism SpectrumThe Parent's Perspectives on Autism Spectrum Disorder
CDC - Reducing Severe Traumatic Brain Injury in the US, Part 3
Grand Rounds Nation®CDC - Reducing Severe Traumatic Brain Injury in the US, Part 3
CDC - Reducing Severe Traumatic Brain Injury in the US, Part 2
Grand Rounds Nation®CDC - Reducing Severe Traumatic Brain Injury in the US, Part 2
- advertisement
CDC - Reducing Severe Traumatic Brain Injury in the US, Part 1
Grand Rounds Nation®CDC - Reducing Severe Traumatic Brain Injury in the US, Part 1
Spotlight on Meningiomas: Risks and Clinical Manifestations
NeuroFrontiersSpotlight on Meningiomas: Risks and Clinical Manifestations
Treating Diabetic Nerve Pain: Guidelines from the American Academy of Neurology
NeuroFrontiersTreating Diabetic Nerve Pain: Guidelines from the American Academy of Neurology
How Smart Phones Are Improving Neurologic Care
NeuroFrontiersHow Smart Phones Are Improving Neurologic Care
The Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease
NeuroFrontiersThe Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease
- advertisement
Neurosurgical Quality Improvement Measures & Patients With Degenerative Disc Disease
Medical Breakthroughs from Penn MedicineNeurosurgical Quality Improvement Measures & Patients With Degenerative Disc Disease
Endoscopic Brain Surgery, In 3-D
Medical Breakthroughs from Penn MedicineEndoscopic Brain Surgery, In 3-D
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3

















































